QIAGEN N.V. (NYSE: QGEN) last traded at $44.07, down 1.85% on the session. The quote above updates while this page is open; the figures below are drawn from QIAGEN N.V.’s own filings and are restated only when a new one is published.
QIAGEN N.V. trades on NYSE under the ticker QGEN. Its market capitalisation is $9.56 billion.
Valuation measures for QIAGEN N.V., derived from the latest quote and its most recent SEC filing.
| Market cap | $9.56B |
|---|---|
| P/E ratio | 22.72 |
| Price / sales | 4.57 |
| Price / book | 2.53 |
| Beta | 0.33 |
Trailing-twelve-month figures tagged in QIAGEN N.V.'s XBRL filings with the SEC.
| Revenue (TTM) | $2.09B |
|---|---|
| Net income (TTM) | $424.88M |
| EPS (TTM) | $1.94 |
| Gross margin | 62.18% |
| Operating margin | 22.29% |
| Return on equity | 11.25% |
| Cash | $839.00M |
Range and volume for QGEN over the past 52 weeks.
| 52-week high | $57.82 |
|---|---|
| 52-week low | $32.53 |
| Volume | 2.90M |
| Average volume | 2.81M |
| Previous close | $44.90 |
Dividend history for QIAGEN N.V. over the trailing twelve months.
| Dividend yield | 0.57% |
|---|---|
| Dividend per share (TTM) | $0.250 |
| Payout ratio | 12.89% |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.